WEHI identifies potential HTLV-1 treatment in collaborative study with Doherty Institute
Posted: 23 July 2025 Approximately 10 million people worldwide are affected by HTLV-1, a virus that can cause severe disease but currently has no cure or preventive therapy. A collaborative study by WEHI and the Peter Doherty Institute…
Brandon BioCatalyst backed by $33 million grant to support biotech startups
Posted: 21 July 2025 Brandon BioCatalyst’s national biotech incubator, CUREator, has received a $33 million grant from the Australian Government’s Medical Research Future Fund (MRFF), bolstering support for early-stage therapeutic companies in both preclinical and clinical development. Through…
Noxopharm marks first dose of SOF-SKN™ in HERACLES clinical trial
Posted: 21 July 2025 Noxopharm has reached a significant milestone with the first dose of its novel candidate SOF-SKN™ administered in the HERACLES clinical trial, a first-in-human study targeting autoimmune skin diseases. Designed to evaluate safety, tolerability, and…
WEHI announces partnership to advance Parkinson’s drug discovery
Posted: 21 July 2025 The Walter and Eliza Hall Institute of Medical Research (WEHI) formed a new partnership with the Parkinson’s Research Foundation in a move aimed at accelerating the development of treatments for Parkinson’s disease. Announced in…
Biointelect awarded $33 Million to lead national research commercialisation initiative
Posted: 21 July 2025 Biointelect has been awarded $33 million by the Australian Government through the Medical Research Future Fund (MRFF) to deliver a new national incubator designed to fast-track the commercialisation of research in vaccines and immune-based…
St Vincent’s launches “ResearchFriends” to empower and connect community voices in medical research
Posted: 21 July 2025 St Vincent’s Hospital Melbourne has launched ResearchFriends, an online platform created to foster stronger, more inclusive partnerships between the public and health researchers. The initiative aims to connect individuals – patients, families, and caregivers –…
ANDHealth secures $33 million to expand leading digital health commercialisation program
Posted: 14 July 2025 Australia’s flagship digital health commercialisation initiative, ANDHealth+, has been awarded $33 million in new funding to broaden its national footprint and support a greater number of emerging digital health companies. The funding, announced by…
University of Melbourne receives $4.4 million funding boost from AEA program
Posted: 8 July 2025 University of Melbourne researchers have secured $4.4M from Australia’s Economic Accelerator (AEA) Innovate program. The funding will enable collaboration with industry partners to bring three research-based technologies to market. The funding had been allocated…
Monash University to lead $25 million mobile CT scanner development project
Posted: 8 July 2025 Monash University has stated it will “lead the design of a first-of-its-kind mobile CT scanner” with Micro-X as part of a $25 million development project. The initiative is being supported by the US Advanced…
Peter Mac researchers progress CAR T-Cell therapy for solid tumours
Posted: 7 July 2025 Researchers at Peter MacCallum Cancer Centre have advanced efforts to harness CAR T-cell therapy against solid tumour cancers, overcoming a major barrier that had limited the treatment’s use beyond blood cancers. The team, led…
Amplia Therapeutics announces additional partial response in Pancreatic Cancer trial
Posted: 7 July 2025 Amplia Therapeutics announced that dosing had been completed for the first group of patients in its ACCENT Phase 2 clinical study evaluating AMP945 combined with gemcitabine and nab-paclitaxel in advanced pancreatic cancer. The ACCENT…
Ego Pharmaceuticals expands local manufacturing with $156 Million investment
Posted: 2 July 2025 Australian skincare manufacturer Ego Pharmaceuticals has unveiled a decade-long $156 million investment to expand its domestic production capabilities, opening the advanced Zorzi Innovation Centre (ZInC) alongside new sustainability and manufacturing upgrades. The announcement was…
